Managing CMV retinitis in the developing world

Community Eye Health

Volumn 16, Issue 47, 2003, Pages 38-39

  Visser, Linda ^a  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; COTRIMOXAZOLE; GANCICLOVIR;

ADULT; CONTROLLED STUDY; CYTOMEGALOVIRUS; DEVELOPING COUNTRY; DISEASE COURSE; ENDOPHTHALMITIS; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPHEMA; MAJOR CLINICAL STUDY; MALE; OPPORTUNISTIC INFECTION; RETINA DETACHMENT; RETINITIS; REVIEW; TREATMENT OUTCOME; UVEITIS; VISUAL ACUITY; VITRECTOMY; VITREOUS HEMORRHAGE;

EID: 2542506328     PISSN: 09536833     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (4)

1. Carmichael T R, Sher R. Screening for cytomegalovirus retinitis at an AIDS clinic. SA Medical Journal 2002; 92: 445-446.
2. Beare N A, Kublin J G, Lewis D K, Schijffelen M J, Peters R P, Joaki G, Kumwenda J, Zijlstra E E. Ocular disease in patients with tuberculosis and HIV presenting with fever in Africa. Br J Ophthalmol 2002; 86: 1076-1079.
3. Studies of the Ocular Complications of AIDS Research Group, in collaboration with the AIDS Clinical Trials Group. Foscarnet-ganciclovir cytomegalovirus retinitis trial 4: visual outcomes. Ophthalmology 1994; 101: 1250-1261.
4. Kempen J H, Jabs D A, Wilson L A, Dunn J P, West S K, Tonascia J A. Risk of vision loss in patients with cytomegalovirus retinitis and the acquired immunodeficiency syndrome. Arch Ophthalmol 2003; 121: 466-475.